News

B dot Medical Selected for the 4th Batch of Tokyo’s “SusHi Tech Global” Startup Support Program

B dot Medical Inc. (Headquarters: Edogawa, Tokyo; President & CEO: Takuji Furukawa) is pleased to announce that it has been selected for the fourth batch of “SusHi Tech Global Startups” under the Tokyo Metropolitan Government’s (TMG) “SusHi Tech Global” initiative, a program that supports global startups possessing technologies that address urban challenges and create new value.


About “SusHi Tech Global”
“SusHi Tech Global” is a program promoted by the TMG to support the global growth of startups. Promising enterprises with innovative technologies and ideas that contribute to solving urban challenges and generating new value are selected as “SusHi Tech Global Startups”. To accelerate their global expansion, the program provides tailored support covering human resources, organizational development, and business and capital strategies, in close collaboration with a diverse network of supporters. Through this initiative, TMG aims to drive global innovation from Tokyo and Japan, working toward the realization of sustainable cities and societies.

New Value Creation by B dot Medical
Proton therapy offers the advantage of minimizing the physical burden on cancer patients, making it easier to balance cancer treatment with everyday life. However, due to the large size and high cost of conventional proton therapy systems, their adoption has been limited to a relatively small number of medical institutions, restricting broader access to this treatment. B dot Medical’s ultra-compact proton therapy system, Phemto®, eliminates the large rotating mechanism used in conventional proton therapy systems through its proprietary Magnetic Gantry™ technology. This innovation successfully reduces the system’s size to approximately one-third and its cost to about one-half, enabling deployment in hospitals located in both domestic and international urban centers—including Tokyo—as well as in regions expanding their medical infrastructure, where installation was previously burdensome.

By expanding access to proton therapy both in Japan and internationally, B dot Medical aims to realize a society where people can continue working while receiving cancer treatment, thereby contributing to the development of sustainable cities and communities.

to Page top